Nello Mainolfi Kymera Therapeutics, Inc. (KYMR) insider trading activity

Nello Mainolfi is Chief Executive Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 663,077 shares of KYMR, which is worth approximately $43.1 Million. The most recent transaction as insider was on Jan 10, 2022, when has been sold 22,465 shares (Common Stock) at a price of $53.8 per share, resulting in proceeds of $1,208,617. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 663K

0.39% 3M change

2.02% 12M change

Total Value Held $43.1 Million

Nello Mainolfi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2022	SELL Open market or private sale	$1,208,617 $53.8 p/Share	22,465 Reduced 4.54%	472,199 Common Stock
Jan 10 2022	BUY Exercise of conversion of derivative security	$46,727 $2.08 p/Share	22,465 Added 4.34%	494,664 Common Stock
Dec 16 2021	BUY Exercise of conversion of derivative security	$16,640 $2.08 p/Share	8,000 Added 1.67%	472,199 Common Stock
Oct 11 2021	SELL Open market or private sale	$348,882 $54.04 p/Share	6,456 Reduced 1.37%	464,199 Common Stock
Oct 11 2021	BUY Exercise of conversion of derivative security	$13,428 $2.08 p/Share	6,456 Added 1.35%	470,655 Common Stock
Oct 08 2021	SELL Open market or private sale	$2,431,155 $58.52 p/Share	41,544 Reduced 8.21%	464,199 Common Stock
Oct 08 2021	BUY Exercise of conversion of derivative security	$86,412 $2.08 p/Share	41,544 Added 7.59%	505,743 Common Stock

Aug 19 2021	BUY Exercise of conversion of derivative security	$24,960 $2.08 p/Share	12,000 Added 2.52%	464,199 Common Stock
Aug 04 2021	SELL Open market or private sale	$62,251 $60.03 p/Share	1,037 Reduced 0.23%	452,199 Common Stock
Aug 04 2021	BUY Exercise of conversion of derivative security	$2,157 $2.08 p/Share	1,037 Added 0.23%	453,236 Common Stock
Aug 03 2021	SELL Open market or private sale	$340,537 $60.07 p/Share	5,669 Reduced 1.24%	452,199 Common Stock
Aug 03 2021	BUY Exercise of conversion of derivative security	$11,792 $2.08 p/Share	5,669 Added 1.22%	457,868 Common Stock
Aug 02 2021	SELL Open market or private sale	$1,436,211 $61.23 p/Share	23,456 Reduced 4.93%	452,199 Common Stock
Aug 02 2021	BUY Exercise of conversion of derivative security	$48,788 $2.08 p/Share	23,456 Added 4.7%	475,655 Common Stock
Jul 30 2021	SELL Open market or private sale	$377,180 $60.07 p/Share	6,279 Reduced 1.37%	452,199 Common Stock
Jul 30 2021	BUY Exercise of conversion of derivative security	$13,060 $2.08 p/Share	6,279 Added 1.35%	458,478 Common Stock
Jul 29 2021	SELL Open market or private sale	$40,800 $60.0 p/Share	680 Reduced 0.15%	452,199 Common Stock
Jul 29 2021	BUY Exercise of conversion of derivative security	$1,414 $2.08 p/Share	680 Added 0.15%	452,879 Common Stock
Jul 28 2021	SELL Open market or private sale	$232,420 $60.15 p/Share	3,864 Reduced 0.85%	452,199 Common Stock
Jul 28 2021	BUY Exercise of conversion of derivative security	$8,037 $2.08 p/Share	3,864 Added 0.84%	456,063 Common Stock
Jul 26 2021	SELL Open market or private sale	$542,252 $60.15 p/Share	9,015 Reduced 1.95%	452,199 Common Stock
Jul 26 2021	BUY Exercise of conversion of derivative security	$18,751 $2.08 p/Share	9,015 Added 1.92%	461,214 Common Stock
Jul 08 2021	SELL Open market or private sale	$2,417,760 $50.37 p/Share	48,000 Reduced 9.6%	452,199 Common Stock
Jul 08 2021	BUY Exercise of conversion of derivative security	$99,840 $2.08 p/Share	48,000 Added 8.76%	500,199 Common Stock
Jun 14 2021	BUY Exercise of conversion of derivative security	$83,200 $2.08 p/Share	40,000 Added 8.13%	452,199 Common Stock

Nello Mainolfi

Chief Executive Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Value

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR

Account